Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 8
1983 9
1984 8
1985 14
1986 13
1987 18
1988 15
1989 29
1990 13
1991 35
1992 22
1993 27
1994 21
1995 24
1996 20
1997 23
1998 29
1999 20
2000 18
2001 14
2002 13
2003 3
2004 3
2005 9
2006 9
2007 7
2008 4
2009 7
2010 2
2011 4
2012 3
2013 4
2014 4
2015 3
2016 2
2017 2
2018 1
2019 1
2020 2
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Ranitidine Use and Incident Cancer in a Multinational Cohort.
You SC, Seo SI, Falconer T, Yanover C, Duarte-Salles T, Seager S, Posada JD, Shah NH, Nguyen PA, Kim Y, Hsu JC, Van Zandt M, Hsu MH, Lee HL, Ko H, Shin WG, Pratt N, Park RW, Reich CG, Suchard MA, Hripcsak G, Park CH, Prieto-Alhambra D. You SC, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2333495. doi: 10.1001/jamanetworkopen.2023.33495. JAMA Netw Open. 2023. PMID: 37725377 Free PMC article.
No significant associations were found between ranitidine use and any secondary outcomes after calibration. CONCLUSIONS AND RELEVANCE: In this cohort study, ranitidine use was not associated with an increased risk of cancer compared with the use of other H2RAs. Furt …
No significant associations were found between ranitidine use and any secondary outcomes after calibration. CONCLUSIONS AND RELEVANCE …
Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial.
Panahi Y, Khedmat H, Valizadegan G, Mohtashami R, Sahebkar A. Panahi Y, et al. J Tradit Chin Med. 2015 Dec;35(6):632-6. doi: 10.1016/s0254-6272(15)30151-5. J Tradit Chin Med. 2015. PMID: 26742306 Free article. Clinical Trial.
OBJECTIVE: To investigate the use of Aloe vera (A. vera) for the treatment of gastroesophageal reflux disease (GERD) symptoms and compare its effects with those of omeprazole and ranitidine. METHODS: In this pilot, randomized controlled trial, 79 subjects were allocated to …
OBJECTIVE: To investigate the use of Aloe vera (A. vera) for the treatment of gastroesophageal reflux disease (GERD) symptoms and compare it …
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Agarwal SM, Stogios N, Ahsan ZA, Lockwood JT, Duncan MJ, Takeuchi H, Cohn T, Taylor VH, Remington G, Faulkner GEJ, Hahn M. Agarwal SM, et al. Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2. Cochrane Database Syst Rev. 2022. PMID: 36190739 Free PMC article. Review.
Other agents that may be slightly effective in preventing weight gain include H2 antagonists such as nizatidine, famotidine and ranitidine (MD -1.32 kg, 95% CI -2.09 to -0.56; 3 studies, 248 participants; low-certainty evidence) and monoamine modulators such as reboxetine …
Other agents that may be slightly effective in preventing weight gain include H2 antagonists such as nizatidine, famotidine and ranitidin …
Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
Gu XJ, Chen R, Sun CH, Zheng W, Yang XH, Wang SB, Ungvari GS, Ng CH, Golenkov A, Lok GKI, Li L, Chow IHI, Wang F, Xiang YT. Gu XJ, et al. J Int Med Res. 2018 Jan;46(1):22-32. doi: 10.1177/0300060517716783. Epub 2017 Jul 18. J Int Med Res. 2018. PMID: 28718688 Free PMC article. Review.
After removing an outlier study for BMI, the effect of ranitidine remained significant. Adjunctive ranitidine outperformed the placebo in the negative symptom score of the Positive and Negative Syndrome Scale. Although ranitidine was associated with less freq …
After removing an outlier study for BMI, the effect of ranitidine remained significant. Adjunctive ranitidine outperformed the …
Low-dose ranitidine for the relief of heartburn.
Pappa KA, Gooch WM, Buaron K, Payne JE, Giefer EE, Sirgo MA, Ciociola AA. Pappa KA, et al. Aliment Pharmacol Ther. 1999 Apr;13(4):459-65. doi: 10.1046/j.1365-2036.1999.00507.x. Aliment Pharmacol Ther. 1999. PMID: 10215729 Free article. Clinical Trial.
Following a 1-week open-label run-in phase to document baseline heartburn frequency, subjects were randomized to receive treatment with one tablet of either ranitidine 75 mg (n = 491), ranitidine 25 mg (n = 504), or placebo (n = 494), to be taken as needed up to fou …
Following a 1-week open-label run-in phase to document baseline heartburn frequency, subjects were randomized to receive treatment with one …
Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J, Matta MK, DePalma R, Gershuny V, Patel V, Hsiao CH, Zusterzeel R, Rouse R, Prentice K, Nalepinski CG, Kim I, Yi S, Zhao L, Yoon M, Selaya S, Keire D, Korvick J, Strauss DG. Florian J, et al. JAMA. 2021 Jul 20;326(3):240-249. doi: 10.1001/jama.2021.9199. JAMA. 2021. PMID: 34180947 Free PMC article. Clinical Trial.
In addition, the petitioner proposed that ranitidine could convert to NDMA in humans; however, this was primarily based on a small clinical study that detected an increase in urinary excretion of NDMA after oral ranitidine consumption. ...No drug-related serious …
In addition, the petitioner proposed that ranitidine could convert to NDMA in humans; however, this was primarily based on a small cl …
Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
Small DS, Farid NA, Li YG, Ernest CS 2nd, Payne CD, Salazar DE, Winters KJ. Small DS, et al. Curr Med Res Opin. 2008 Aug;24(8):2251-7. doi: 10.1185/03007990802205985. Curr Med Res Opin. 2008. PMID: 18786302 Clinical Trial.
Ranitidine did not affect prasugrel IPA during MD. For clopidogrel, IPA was not affected by ranitidine. Prasugrel and clopidogrel were both well-tolerated, with/without ranitidine. CONCLUSIONS: Results from this study suggest that there is no significant drug …
Ranitidine did not affect prasugrel IPA during MD. For clopidogrel, IPA was not affected by ranitidine. Prasugrel and clopidog …
Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study.
Montero Pérez O, Martinez Benavides J, González Fernandez T, Guerra Prio S, Romero Domínguez R, Mesía Nin R, Clopés Estela A. Montero Pérez O, et al. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):877-883. doi: 10.1080/17512433.2023.2238596. Epub 2023 Jul 21. Expert Rev Clin Pharmacol. 2023. PMID: 37477611 Clinical Trial.
BACKGROUND: Histamine type-2-receptor antagonist drugs (H2-antagonists) have been used as standard treatment to prevent hypersensitivity reactions (HRs) in paclitaxel-containing regimens, however, their use has been strongly questioned. Ranitidine has been the most widely …
BACKGROUND: Histamine type-2-receptor antagonist drugs (H2-antagonists) have been used as standard treatment to prevent hypersensitivity rea …
Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ. Richter JE, et al. Am J Gastroenterol. 1996 Sep;91(9):1766-72. Am J Gastroenterol. 1996. PMID: 8792695 Clinical Trial.

At wk 8, 80% of patients with esophagitis grade 2 or higher at entry were healed with omeprazole (p < 0.001 vs ranitidine [40%] and ranitidine/metoclopramide [46%]). Thirty-four percent of patients reported an adverse event. ...The addition of metocloprami

…

At wk 8, 80% of patients with esophagitis grade 2 or higher at entry were healed with omeprazole (p < 0.001 vs ranitidine [40%] an

…
Confounding by indication?
Shapiro S. Shapiro S. Epidemiology. 1997 Jan;8(1):110-1. Epidemiology. 1997. PMID: 9116082 Clinical Trial. No abstract available.
465 results

Searches related to "ranitidine adverse"